Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification by Guldvik, Ingrid J., Zuber, Verena, Braadland, Peder R., Grytli, Helene H., Ramberg, Håkon, Lilleby, Wolfgang, Thiede, Bernd, Zucknick, Manuela, Saatcioglu, Fahri, Gislefoss, Randi, Kvåle, Rune, George, Anne, Grönberg, Henrik, Wiklund, Fredrik, Neal, David E., Gnanapragasam, Vincent J., Taskén, Kristin A., Mills, Ian G.

Get full text

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy by Braadland, Peder R, Giskeødegård, Guro, Sandsmark, Elise, Bertilsson, Helena, Euceda, Leslie R, Hansen, Ailin F, Guldvik, Ingrid J, Selnæs, Kirsten M, Grytli, Helene H, Katz, Betina, Svindland, Aud, Bathen, Tone F, Eri, Lars M, Nygård, Ståle, Berge, Viktor, Taskén, Kristin A, Tessem, May-Britt

Get full text

Role of serum response factor expression in prostate cancer biochemical recurrence by Prencipe, Maria, Fabre, Aurelie, Murphy, Thomas Brendan, Vargyas, Eszter, O'Neill, Amanda, Bjartell, Anders, Tasken, Kristin Austlid, Grytli, Helene H., Svindland, Aud, Berge, Viktor, Eri, Lars M., Gallagher, William, Watson, R. William

Get full text

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy by Braadland, Peder R, Giskeødegård, Guro, Sandsmark, Elise, Bertilsson, Helena, Euceda, Leslie R, Hansen, Ailin F, Guldvik, Ingrid J, Selnæs, Kirsten M, Grytli, Helene H, Katz, Betina, Svindland, Aud, Bathen, Tone F, Eri, Lars M, Nygård, Ståle, Berge, Viktor, Taskén, Kristin A, Tessem, May-Britt

Get full text

Abstract B015: Potential systemic effects of beta-blocker use in prostate cancer patients by Grytli, Helene H., Ramberg, Haakon, Braadland, Peder R., Nielsen, Heidi K., Guldvik, Ingrid J., Taskén, Kristin A.

Get full text

Erratum: Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy by Braadland, Peder R, Giskeødegård, Guro, Sandsmark, Elise, Bertilsson, Helena, Euceda, Leslie R, Hansen, Ailin F, Guldvik, Ingrid J, Selnæs, Kirsten M, Grytli, Helene H, Katz, Betina, Svindland, Aud, Bathen, Tone F, Eri, Lars M, Nygård, Ståle, Berge, Viktor, Taskén, Kristin A, Tessem, May-Britt

Get full text

Abstract A13: β2-adrenergic receptor as a potential differentiation marker in prostate cancer by Ramberg, Håkon, Grytli, Helene H., Braadland, Peder R., Wang, Wanzhong, Nielsen, Heidi K., Krobert, Kurt A., Levy, Finn Olav, Bjartell, Anders, Svindland, Aud, Taskén, Kristin Austlid

Get full text

PBX3 is a putative biomarker of aggressive prostate cancer by Ramberg, Håkon, Grytli, Helene Hartvedt, Nygård, Ståle, Wang, Wanzhong, Ögren, Olov, Zhao, Sen, Løvf, Marthe, Katz, Betina, Skotheim, Rolf I., Bjartell, Anders, Eri, Lars Magne, Berge, Viktor, Svindland, Aud, Taskén, Kristin Austlid

Get full text

β-Adrenergic Receptor Signaling in Prostate Cancer by Braadland, Peder Rustøen, Ramberg, Håkon, Grytli, Helene Hartvedt, Taskén, Kristin Austlid

Get full text